01.06.2026
... -Technologien, die letztlich zur Genentech/Roche-Therapie KADCYLA® beitrugen, die 2013 ...
30.05.2026
... -2,09%, Merck Co. -3,01%, Roche GS -3,85%, Bayer -5,14%, Fresenius ... 65% , Lanxess -8,33% , Epigenomics -8,58% , Roche GS -10,47% , Fresenius -11 ...
30.05.2026
... -2,07%, Johnson & Johnson -3,84%, Roche GS -3,85%, Intel -4,31% und ... , Toyota Motor Corp. -2,1% , Sanofi -4,56% , Roche GS -10,47% und GlaxoSmithKline ...
23.05.2026
... BB Biotech -1,23%, BASF -1,82%, Roche GS -3,85%, Epigenomics -6,99%, Lanxess ... , Epigenomics -8,58% , Fresenius -10,38% , Roche GS -10,47% , Medigene -12 ...
23.05.2026
... Corp. -2,13%, Alphabet -3,54%, Roche GS -3,85% und GlaxoSmithKline -19 ... , Pfizer -5,16% , Toyota Motor Corp. -7% , Roche GS -10,47% und GlaxoSmithKline ...
16.05.2026
... Amgen -1,62%, Baxter International -3,84%, Roche GS -3,85%, Ibu-Tec -4,55 ... , Sanofi -8,71% , Sartorius -10,21% , Roche GS -10,47% , Stratec Biomedical ...
16.05.2026
... -1,36%, Zumtobel -1,94%, Amazon -3,13%, Roche GS -3,85%, IBM -4,55%, Samsung ... -8,17% , Sanofi -8,71% , IBM -8,73% , Roche GS -10,47% und GlaxoSmithKline ...
09.05.2026
... 47%, Bayer -2,81%, Lanxess -3,8%, Roche GS -3,85%, BASF -5,64%, ... , Valneva -6,8% , Epigenomics -8,58% , Sanofi -9,2% , Roche GS -10,47% , Medigene -12 ...
09.05.2026
... -2,47%, Johnson & Johnson -2,58%, Roche GS -3,85%, Sanofi -8,42% und ... , Toyota Motor Corp. -7,36% , Sanofi -9,2% , Roche GS -10,47% und GlaxoSmithKline ...